Proteostasis Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch PTI and buy or sell other stocks, ETFs, and their options commission-free!About PTI
Kineta, Inc. is a clinical-stage biotechnology company, which engages in the development of immunotherapies for cancer patients. Its pipeline includes immuno-suppression: aVISTA mAb and exhausted T-cells: aCD27 agonist mAb.
CEOShawn P. Iadonato, PhD
CEOShawn P. Iadonato, PhD
Employees5
Employees5
HeadquartersMercer Island, Washington
HeadquartersMercer Island, Washington
Founded2008
Founded2008
Employees5
Employees5
PTI Key Statistics
Market cap25.59M
Market cap25.59M
Price-Earnings ratio-0.50
Price-Earnings ratio-0.50
Dividend yield—
Dividend yield—
Average volume15.46K
Average volume15.46K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$1.15
52 Week high$1.15
52 Week low$0.1806
52 Week low$0.1806
Stock Snapshot
As of today, Proteostasis Therapeutics(PTI) shares are valued at $1.89. The company's market cap stands at 25.59M, with a P/E ratio of -0.50.
During the trading day, Proteostasis Therapeutics(PTI) stock saw an opening price of —, a peak of —, and a bottom of —.
Trading volume for Proteostasis Therapeutics(PTI) stock has reached 0, versus its average volume of 15.46K.
Over the past 52 weeks, Proteostasis Therapeutics(PTI) stock has traded between a high of $1.15 and a low of $0.18.
Over the past 52 weeks, Proteostasis Therapeutics(PTI) stock has traded between a high of $1.15 and a low of $0.18.
People also own
Based on the portfolios of people who own PTI. This list is generated using Robinhood data, and it’s not a recommendation.